inbiome

🎄✨ From Lab to Table: A Christmas Transformation! 🍽️ This week the Inbiome Concept Lab boldly ventured into uncharted territory—it became a Concept Restaurant! 🎅🏼🍷 Our brilliant team swapped their lab coats for Christmas crowns, and instead of working on our Molecular Culture assay, we worked on growing closer over an extravagant Christmas feast served by a top-notch hospitality team. 🍴✨ But the real science happened when we cracked open Christmas crackers—because everyone knows true innovation comes with your very own elf name! 🧝🎉 Spoiler alert: Santa’s research department might be calling us soon. This evening was a delightful mix of questionable cracker jokes and discovering who can pull off an elf hat. 🌟❤️ To all our customers, lab fellows, office heroes, and holiday enthusiasts: May your season be filled with joy, laughter, good health, and food that doesn’t require a pipette! 🥂🎁 #inbiome #Christmas #TeamInbiome #HolidayCheers #MolecularCulture #ConceptRestaurant

We’re pleased to be featured by I amsterdam as one of the Healthcare and MedTech Companies to Watch in Amsterdam. It’s great to be included alongside innovative companies like Lapsi Health, Pacmed, Castor, Kepler Vision Technologies, Aidence, SkinVision, Ellogon.AI, Confocal.nl, LUMICKS, Sigma Screening BV, WSK Medical, and Neogene Therapeutics. Amsterdam’s MedTech community continues to grow, and we’re proud to be part of it, working to advance healthcare diagnostics and solutions. Thank you to I Amsterdam for highlighting the valuable work being done in our sector. You can read the full article here: https://lnkd.in/e2A9_SQp #MedTech #HealthcareInnovation #AmsterdamLifeSciences #InBiome

🎁 Sinterklaas Surprises at Inbiome 🎁 At Inbiome, the Sint made his stop, With surprises galore from our creative shop. From a disco scene that lights up the floor, To a cozy chalet with snowy décor. Our team of ten nations brought joy and delight, From tiny details to visions so bright. A hot tub with bubbles, mushrooms galore, Every creation left us wanting more! It’s the power of minds, both creative and keen, With science and fun, the best ever seen. From labs to crafts, we make an impact, On Molecular Culture, our skills are stacked. Together we show, year after year, That diverse perspectives make our goals clear. So thank you, dear Sint, for sparking this cheer, Here’s to Inbiome and an exciting new year! #Sinterklaas #Inbiome #DiversityInScience #CreativeTeamwork 🎉

🌍 World AMR Awareness Week: Combating Antimicrobial Resistance with DARTBAC 🦠 According to the World Health Organization, Antimicrobial resistance (AMR) is currently one of the top global health threats. As AMR rises, finding innovative infection-fighting solutions is more urgent than ever. That’s why inbiome is proud to collaborate with DARTBAC, a nationwide consortium advancing technologies to address AMR. Our Molecular Culture ID technology is being tested at Maastricht UMC+ by PhD researcher Elizabeth Morreel as a rapid diagnostic tool for joint infections, in particular focusing on the added value of Molecular Culture ID in sonication fluid. Recently, our team member Martine Bos joined the DARTBAC meeting to share insights and strengthen collaborations, emphasizing the key role of fast diagnostics in combatting AMR. During World AMR Awareness Week, let’s spotlight the power of partnerships in creating a future resilient to AMR. #AMRAwareness #DARTBAC #MolecularCulture #WorldAMRWeek #InnovationAgainstAMR

Yesterday, inbiome’s founders engaged in insightful discussions with Florida’s Secretary of Health Care Administration, Jason Weida, and representatives from major hospitals across Florida at the Medica 2024 conference in Düsseldorf. Our conversations centered on how inbiome’s Molecular Culture technology can enhance bacterial diagnostics, leading to faster and more accurate patient care. By integrating our advanced molecular solutions, we aim to support Florida’s healthcare system in delivering timely and precise treatments, ultimately improving patient outcomes and reducing healthcare costs. We are excited about the potential collaborations ahead and are committed to contributing to advancing healthcare in Florida.   Thank you for the great conversations Jason Weida, George Godfrey of BAPTIST HEALTH SOUTH FLORIDA FOUNDATION INC, David Zambrana of Jackson Health System, Tom Gillette of Mount Sinai Health System, Troy Keyser of HCA Healthcare and Brian Hammond of Tampa General Hospital

🎃 Halloween at Inbiome HQ! 🧫👻 Our team got into the Halloween spirit this year, trading lab coats for costumes and adding a dash of fun to the office! From witches to lab-grown monsters, we're celebrating the season with a little microbiological twist. 🦠 Bacterial diagnostics has its own share of mysteries, and every day, our team works to uncover them, making microbial identification clearer and more accessible for our users. Our latest diagnostic products are brewing in the lab, aimed at making bacterial identification faster, precise, and insightful. Stay tuned for updates, and enjoy the season’s thrills and chills! 🎉👩🔬🧛 #Halloween #MolecularCulture #Diagnostics

🔬 Can we predict COPD exacerbations using microbiome analysis? REDALERT Project update! 🔬   Why is it so important to predict acute exacerbations in COPD patients? These flare-ups can have a huge impact on patients, often leading to hospital stays and, in severe cases, becoming life-threatening. Right now, most strategies only step in after an exacerbation occurs. But imagine if we could prevent them before they even happen? That’s exactly what we’re aiming for with the REDALERT project, supported by the Eurostars program! Together with our partners at geneXplain, the Department of Respiratory Medicine at the Goethe-Universität Frankfurt a. Main, and Maastricht UMC+, we’ve enrolled 125 COPD patients across Frankfurt and at MUMC. These patients provide regular throat swabs, which we analyze using Molecular Culture to explore their respiratory microbiome. By pairing the microbiome data with clinical parameters, our goal is to develop a predictive algorithm that could anticipate exacerbations before they happen. With Eurostars' support, this collaborative project is making steady progress, and we’re confident it will lead to impactful insights for COPD management. We look forward to sharing more updates as we continue this important work! #EREDALERT #COPDResearch #Eurostars #Microbiome

🌟 Inbiome's Quarterly Event: Reflect, Reset, and Recharge! 🌟 As we wrap up another successful quarter at Inbiome, it's time to gather, reflect on our accomplishments, and set ambitious goals for the upcoming quarter and year ahead. 🚀 This quarterly event is more than just a meeting—it's an opportunity to celebrate our progress, align on future goals, and continue our journey of innovation in the microbiology space. And of course, we believe in balancing hard work with fun! As always, we will conclude the event with some well-deserved downtime, the whole team enjoyed a lively Music Bingo session, followed by drinks and a delicious dinner to unwind and connect. 🔗 Stay tuned for more insights and updates! Be sure to follow us here on LinkedIn to stay in the loop with all things inbiome. #inbiome #molecularculture #Innovation #Teamwork

🦠🌍 The Role of Diagnostics in the Fight Against Antimicrobial Resistance (AMR) In the recent declaration by world leaders at the United Nations, there was a clear commitment to decisive action on #AntimicrobialResistance. To turn this commitment into reality, there’s a critical piece of the puzzle we must address: Diagnostics.  The AMR crisis has been described as an arms race, one that we are not currently winning. Bacteria are evolving faster than our ability to develop new antibiotics. However, this arms race is not one we can win through antibiotics alone. 🔬 Better diagnostics are essential to break this cycle. Without rapid, precise diagnostics: - Patients continue to receive broad-spectrum antibiotics, driving resistance. - Healthcare providers are unable to target treatments effectively, leading to the overuse and misuse of antimicrobials. At inbiome, we are working to provide cutting-edge diagnostic solutions that empower healthcare professionals to detect pathogens faster and more accurately. Our advanced molecular diagnostics enable: ✅ Targeted therapies, minimizing unnecessary antibiotic use. ✅ Rapid identification of pathogens, allowing for precise treatment and improved patient outcomes. ✅ A proactive approach to slowing down the evolution of resistance. We believe that the fight against AMR can only be won through a combination of innovative diagnostics and therapy based on specific outcomes. At InBiome, we are proud to be part of this solution, ensuring that the future of global health is driven by precision and sustainability. 🌍💉🔎 #AMR #Diagnostics #GlobalHealth #AntibioticResistance #WHO #InBiome https://lnkd.in/eZXgY5Cv

Breaking news: Molecular Culture receives FDA Breakthrough Device Designation! We are honored to announce that we have received the FDA's Breakthrough Device Designation for our Molecular Culture ID technology! This designation will greatly help us to bring our diagnostic test to the U.S. market. This exceptional designation is awarded to medical devices that offer significant advantages over existing options, to speed-up clinical implementation of critical innovations in the U.S. It not only accelerates the regulatory review process but also facilitates more efficient reimbursement pathways. Our Molecular Culture ID test can rapidly detect and identify over 200 bacterial species in clinical samples, providing same-day, highly accurate diagnoses. This will lead to quicker, more precise patient treatment, saving lives, and improving patient outcomes. We're grateful for the support from our partners, the European Innovation Council (EIC), and our dedicated team. Together, we're making significant strides in the global fight against antimicrobial resistance. Read more about this exciting milestone and what it means for the future of healthcare in our press release: https://lnkd.in/eRnMSGNW #Inbiome #BreakthroughDevice #MolecularCultureID #Healthcare #InfectiousDiseases #Diagnostics #AMR